News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

What's On 'KLH?

Hire Me MKE

HireMeMKE_620x400

Looking for a job around the Milwaukee area? Check out some openings>>

Wanna Play DJ?

HEYMOM

You can host your own show Sunday night at 6 on ‘KLH!

Recent Headlines

in National

Police seek motive in fatal Washington state school shooting

mp

Authorities are seeking a motive as to why a high school student shot dead a female classmate and wounded four others.

in Entertainment

This weekend in entertainment history

beatles

A look back on some of Hollywood's most memorable moments.

in Sports

This week’s top sports shots

royals

A look at some of this week's best moments in sports.